Log In
BCIQ
Print this Print this
 

HLD100

Also known as: HLD-100

  Manage Alerts
Collapse Summary General Information
Company Highland Therapeutics Inc.
DescriptionDelayed- and extended-release formulation of dextroamphetamine sulfate
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat ADHD
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today